Terms: = Lymphoma AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476
92 results:
1. Budget Impact of Introducing Fixed-Duration Mosunetuzumab for the Treatment of Relapsed or Refractory Follicular lymphoma After Two or More Lines of Systemic Therapy in the USA.
Lin SW; Shapouri S; Parisé H; Bercaw E; Wu M; Kim E; Matasar M
Pharmacoeconomics; 2024 May; 42(5):569-582. PubMed ID: 38300452
[TBL] [Abstract] [Full Text] [Related]
2. Treatment patterns and clinical outcomes of mantle cell lymphoma: A retrospective cohort study by CHOICE.
Zeng D; Fang Y; Fei Y; Liang R; Ye H; Liang Y; Sun X; Wang M; Huang H; Qiu L; Che Y; Liu P; Wang Y; Pan T; Lv Y; Deng J; Yi S; He Y; Xiao L; Lv H; Feng J; Zhang H; Zhou H; Zou D; Cai Q
Int J Cancer; 2023 Sep; 153(5):1016-1025. PubMed ID: 37204683
[TBL] [Abstract] [Full Text] [Related]
3. Incremental health care expenditures for non-Hodgkin lymphoma in comparison with other cancers: Analysis of national survey data.
Zakeri M; Li J; Sansgiry SS; Aparasu RR
J Manag Care Spec Pharm; 2023 May; 29(5):480-489. PubMed ID: 37121258
[No Abstract] [Full Text] [Related]
4. Nelarabine-induced myelopathy in patients undergoing allogeneic hematopoietic cell transplantation: a report of three cases.
Fukuta T; Tanaka T; Hashimoto T; Isahaya K; Kubo Y; Yamano Y; Satomi K; Hiraoka N; Shirakawa N; Arakawa A; Ogawa C; Nishimura N; Aoki J; Ito A; Inamoto Y; Kim SW; Fukuda T
Int J Hematol; 2023 Jun; 117(6):933-940. PubMed ID: 36705847
[TBL] [Abstract] [Full Text] [Related]
5. Primary lymphoma of the kidney: Pathology experience from 2 tertiary hospitals in Western Saudi Arabia.
Al-Maghrabi JA
Saudi Med J; 2023 Jan; 44(1):29-37. PubMed ID: 36634947
[TBL] [Abstract] [Full Text] [Related]
6. Salivary gland tumours: an epidemiological review of non-neoplastic and neoplastic pathology.
Mckenzie J; Lockyer J; Singh T; Nguyen E
Br J Oral Maxillofac Surg; 2023 Jan; 61(1):12-18. PubMed ID: 36623970
[TBL] [Abstract] [Full Text] [Related]
7. Diabetes, metformin use and risk of non-Hodgkin's lymphoma in postmenopausal women: A prospective cohort analysis in the Women's Health Initiative.
Wang Z; Phillips LS; Rohan TE; Ho GYF; Shadyab AH; Bidulescu A; Rudick CN; Pan K; Chen Z; Luo J
Int J Cancer; 2023 Apr; 152(8):1556-1569. PubMed ID: 36444502
[TBL] [Abstract] [Full Text] [Related]
8. Core Needle Biopsy in lymphoma Diagnosis: The Diagnostic Performance and the Role of the Multidisciplinary Approach in the Optimization of Results.
Gonçalves MC; de Oliveira CRGCM; Sandes AF; Rodrigues CA; Novis Y; Viana PCC; Serra MMP; Zerbini MCN
Am J Surg Pathol; 2023 Jan; 47(1):111-123. PubMed ID: 36395467
[TBL] [Abstract] [Full Text] [Related]
9. Anti-spike T-cell and Antibody Responses to SARS-CoV-2 mRNA Vaccines in Patients with Hematologic Malignancies.
Greenberger LM; Saltzman LA; Gruenbaum LM; Xu J; Reddy ST; Senefeld JW; Johnson PW; Fields PA; Sanders C; DeGennaro LJ; Nichols GL
Blood Cancer Discov; 2022 Nov; 3(6):481-489. PubMed ID: 36074641
[TBL] [Abstract] [Full Text] [Related]
10. Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China.
Wen Q; Ge J; Lei Y; Zhang Y; Kong X; Wang W; Hou H; Wang Z; Qian S; Ding M; Dong M; Zhu L; Zhang M; Zhang X; Chen Q
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3989-4003. PubMed ID: 36030432
[TBL] [Abstract] [Full Text] [Related]
11. Cardiopulmonary predictors of mortality in patients with COVID-19: What are the findings?
Kavosi H; Nayebi Rad S; Atef Yekta R; Tamartash Z; Dini M; Javadi Nejad Z; Aghaghazvini L; Javinani A; Mohammadzadegan AM; Fotook Kiaei SZ
Arch Cardiovasc Dis; 2022; 115(6-7):388-396. PubMed ID: 35752584
[TBL] [Abstract] [Full Text] [Related]
12. Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia.
Bontoux C; Simonin M; Garnier N; Lhermitte L; Touzart A; Andrieu G; Bruneau J; Lengliné E; Plesa A; Boissel N; Baruchel A; Bertrand Y; Molina TJ; Macintyre E; Asnafi V
Mod Pathol; 2022 Sep; 35(9):1227-1235. PubMed ID: 35562412
[TBL] [Abstract] [Full Text] [Related]
13. Autologous stem cell transplantation for large B-cell lymphoma with secondary central nervous system involvement.
Akin S; Hosing C; Khouri I; Ahmed S; Alousi A; Fowler N; Joseph J; Truxillo J; Ramdial JL; Maadani F; Rondon G; Daher M; Im JS; Steiner R; Westin J; Iyer SP; Dabaja B; Anderlini P; Popat UR; Qazilbash MH; Flowers CR; Shpall E; Champlin RE; Nieto Y; Srour SA
Blood Adv; 2022 Apr; 6(7):2267-2274. PubMed ID: 35008100
[TBL] [Abstract] [Full Text] [Related]
14. Clinical outcomes of relapsed and refractory Hodgkin lymphoma patients after contemporary first-line treatment: a German Hodgkin Study Group analysis.
Bröckelmann PJ; Müller H; Gillessen S; Yang X; Koeppel L; Pilz V; Marinello P; Kaskel P; Raut M; Fuchs M; Borchmann P; Engert A; von Tresckow B
Leukemia; 2022 Mar; 36(3):772-780. PubMed ID: 34628472
[TBL] [Abstract] [Full Text] [Related]
15. Characterization of Second Primary Malignancies in Mucosa-Associated Lymphoid Tissue lymphomas: A SEER Database Interrogation.
Timilsina S; Damato A; Budhathoki N; Grossbard ML; Braunstein M
Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):76-81. PubMed ID: 34493476
[TBL] [Abstract] [Full Text] [Related]
16. A cost-effectiveness analysis of front-line treatment strategies in early-stage follicular lymphoma.
Tobin JWD; Crothers A; Ma TE; Mollee P; Gandhi MK; Scuffham P; Hapgood G
Leuk Lymphoma; 2021 Dec; 62(14):3484-3492. PubMed ID: 34323129
[TBL] [Abstract] [Full Text] [Related]
17. Health disparities experienced by Black and Hispanic Americans with multiple myeloma in the United States: a population-based study.
Al Hadidi S; Dongarwar D; Salihu HM; Kamble RT; Lulla P; Hill LC; Carrum G; Ramos CA; Heslop HE; Usmani SZ
Leuk Lymphoma; 2021 Dec; 62(13):3256-3263. PubMed ID: 34278937
[TBL] [Abstract] [Full Text] [Related]
18. Cost Effectiveness Analysis of Tisagenlecleucel for the Treatment of Adult Patients with Relapsed or Refractory Diffuse Large B Cell lymphoma in Japan.
Wakase S; Teshima T; Zhang J; Ma Q; Fujita T; Yang H; Chai X; Qi CZ; Liu Q; Wu EQ; Igarashi A
Transplant Cell Ther; 2021 Jun; 27(6):506.e1-506.e10. PubMed ID: 33823168
[TBL] [Abstract] [Full Text] [Related]
19. Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin lymphoma: Results of a Phase I Study.
Seymour EK; Khan HY; Li Y; Chaker M; Muqbil I; Aboukameel A; Ramchandren R; Houde C; Sterbis G; Yang J; Bhutani D; Pregja S; Reichel K; Huddlestun A; Neveux C; Corona K; Landesman Y; Shah J; Kauffman M; Shacham S; Mohammad RM; Azmi AS; Zonder JA
Clin Cancer Res; 2021 Jun; 27(12):3307-3316. PubMed ID: 33785483
[TBL] [Abstract] [Full Text] [Related]
20. Efficacy and safety of new anti-CD20 monoclonal antibodies versus rituximab for induction therapy of CD20
Luo C; Wu G; Huang X; Ma Y; Zhang Y; Song Q; Xie M; Sun Y; Huang Y; Huang Z; Hou Y; Xu S; Chen J; Li X
Sci Rep; 2021 Feb; 11(1):3255. PubMed ID: 33547368
[TBL] [Abstract] [Full Text] [Related]
[Next]
